Apertura Gene Therapy

Apertura is a biotechnology company opening opportunities for treating currently intractable diseases. Apertura develops genetic medicines by simultaneously engineering AAV capsids, genetic regulatory elements, and payloads to overcome limitations in cellular access, gene expression, pre-existing immunity, and manufacturability. Apertura is committed to growing the field of gene therapy and believes that together we maximize our impact by working with corporate and academic partners, patients, and foundations. Founded on technologies from the Broad Institute and Harvard Medical School, and with support from Deerfield Management Company, the company is based at the Cure, Deerfield’s innovation campus in New York City.